Two Sigma Securities’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $400K | Sell |
1,367
-415
| -23% | -$136K | 0.05% | 581 |
|
|
2025
Q4 | $625K | Buy |
+1,782
| New | +$602K | 0.09% | 305 |
|
|
2025
Q3 | – | Sell |
-2,224
| Closed | -$865K | – | 1557 |
|
|
2025
Q2 | $865K | Sell |
2,224
-824
| -27% | -$331K | 0.11% | 239 |
|
|
2025
Q1 | $1.33M | Buy |
3,048
+1,348
| +79% | +$541K | 0.2% | 100 |
|
|
2024
Q4 | $627K | Sell |
1,700
-2,476
| -59% | -$1.04M | 0.08% | 284 |
|
|
2024
Q3 | $2.17M | Buy |
4,176
+1,291
| +45% | +$690K | 0.04% | 511 |
|
|
2024
Q2 | $1.56M | Sell |
2,885
-814
| -22% | -$430K | 0.02% | 840 |
|
|
2024
Q1 | $1.92M | Buy |
3,699
+2,571
| +228% | +$1.28M | 0.02% | 771 |
|
|
2023
Q4 | $532K | Sell |
1,128
-317
| -22% | -$147K | 0.01% | 1517 |
|
|
2023
Q3 | $629K | Sell |
1,445
-1,311
| -48% | -$595K | 0.01% | 1361 |
|
|
2023
Q2 | $1.22M | Sell |
2,756
-174
| -6% | -$80.3K | 0.02% | 851 |
|
|
2023
Q1 | $1.35M | Buy |
2,930
+1,165
| +66% | +$554K | 0.03% | 692 |
|
|
2022
Q4 | $905K | Sell |
1,765
-503
| -22% | -$255K | 0.03% | 738 |
|
|
2022
Q3 | $1.03M | Buy |
+2,268
| New | +$1.09M | 0.03% | 619 |
|
|
2022
Q2 | – | Sell |
-573
| Closed | -$281K | – | 2379 |
|
|
2022
Q1 | $281K | Buy |
+573
| New | +$262K | 0.01% | 1455 |
|
|
2021
Q4 | – | Sell |
-936
| Closed | -$394K | – | 1664 |
|
|
2021
Q3 | $349K | Buy |
+936
| New | +$356K | 0.01% | 925 |
|
|
2021
Q2 | – | Sell |
-911
| Closed | -$348K | – | 1541 |
|
|
2021
Q1 | $327K | Buy |
+911
| New | +$293K | 0.02% | 407 |
|
|
2020
Q4 | – | Sell |
-1,013
| Closed | -$311K | – | 1739 |
|
|
2020
Q3 | $272K | Buy |
1,013
+192
| +23% | +$51.7K | 0.01% | 922 |
|
|
2020
Q2 | $216K | Buy |
+821
| New | +$219K | ﹤0.01% | 1096 |
|
|
2019
Q4 | – | Sell |
-1,825
| Closed | -$502K | – | 2400 |
|
|
2019
Q3 | $438K | Buy |
+1,825
| New | +$500K | ﹤0.01% | 1292 |
|
|
2018
Q3 | – | Sell |
-1,449
| Closed | -$376K | – | 2678 |
|
|
2018
Q2 | $345K | Sell |
1,449
-828
| -36% | -$192K | ﹤0.01% | 1970 |
|
|
2018
Q1 | $500K | Buy |
+2,277
| New | +$535K | ﹤0.01% | 1654 |
|
|
2017
Q3 | – | Sell |
-1,702
| Closed | -$320K | – | 988 |
|
|
2017
Q2 | $320K | Sell |
1,702
-1,205
| -41% | -$217K | 0.06% | 331 |
|
|
2017
Q1 | $481K | Sell |
2,907
-2,329
| -44% | -$370K | 0.09% | 205 |
|
|
2016
Q4 | $753K | Buy |
5,236
+2,354
| +82% | +$315K | 0.25% | 79 |
|
|
2016
Q3 | $361K | Buy |
+2,882
| New | +$372K | 0.12% | 245 |
|
Other funds holding ELV
VCM
VPM
Two Sigma Securities's ELV Position: Q1 2026 in Review
Two Sigma Securities reduced its Elevance Health (ELV) stake by 23% in Q1 2026, selling an estimated $136K and leaving 1,367 shares worth $400K. The position accounts for 0.05% of the portfolio, ranked #581.
Two Sigma Securities first reported a position in ELV in Q3 2016 and has held it in 26 quarters since. The position peaked at $2.17M in Q3 2024. 1,464 funds tracked by Wall St. Rank hold ELV as of Q1 2026.
- Two Sigma Securities held 1,367 shares of Elevance Health worth $400K as of Q1 2026.
- Two Sigma Securities sold 415 Elevance Health shares in Q1 2026, an estimated $136K.
- Elevance Health made up 0.05% of Two Sigma Securities's portfolio in Q1 2026, its #581 holding.
- Two Sigma Securities first reported a position in Elevance Health in Q3 2016 and has held it in 26 quarters since.
- Two Sigma Securities's Elevance Health position peaked at $2.17M in Q3 2024.
- 1,464 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.
Based on Two Sigma Securities's 13F filing for Q1 2026, filed 15 May 2026.